Start-Up Previews (03/07)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: Do-It-Yourself Dermatology, features profiles of Therative and Xthetix. Plus these Start-Ups Across Health Care: iCardiac Technologies, Jenken Biosciences, Neovasc Medical, and Syntaxin.
You may also be interested in...
With one look at the technology and some research into the acne market, Therative came to a quick contrarian conclusion: to sell its acne treatment device directly to the 45 million Americans who need it, not to the thousands of dermatologists who treat only 20% of those millions. And so Therative entered the home-use aesthetic market.
Neovasc Medical intends to provide a solution for the millions of patients that can't benefit from bypass, PCIs and other traditional revascularization techniques. It has developed a minimally invasive procedure in which a stent inserted percutaneously into the coronary sinus partially restricts the flow of blood exiting into the arteries. The blood flows backwards into the heart, retroperfusing the tissue and reducing symptoms of ischemia.
As venture capitalists begin counting cosmetics and aesthetics companies as part of their portfolios, they're also migrating toward investing in consumer-oriented companies including those that make aesthetic devices to be used in the home.